Reshaping Vision Possibilities
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on near vision correction. They developed Qlosi (pilocarpine hydrochloride 0.4%), a preservative-free prescription eye drop FDA-approved in 2023 for the treatment of presbyopia in adults. The company targets the nearly 128 million Americans living with age-related blurry near vision as an alternative to reading glasses or surgery.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account